SEC Info - Kirk Randal J, et al. - ‘SC 13D/A’ on 7/6/16 re: Ziopharm Oncology Inc

SEC Info℠

Home

Help

Please Sign In

Kirk Randal J, et al. – ‘SC 13D/A’ on 7/6/16 re: Ziopharm Oncology Inc

On: Wednesday, 7/6/16, at 4:25pm ET · Accession #: 1140361-16-71797 · File #: 5-79364

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 7/06/16  Kirk Randal J                     SC 13D/A               2:56K  Ziopharm Oncology Inc             Summit Fin’l Printing
          Intrexon Corp

Amendment to General Statement of Beneficial Ownership — Sch. 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Randal J. Kirk Sc 13Da No. 8 6-29-2016 (Ziopharm    HTML     38K 
                          Oncology, Inc.)                                        
 2: EX-3        Articles of Incorporation/Organization or By-Laws   HTML      7K

Filing Submission 0001140361-16-071797 – SGML Text

Original SGML Text submitted by:	Broadridge Financial Solutions, Inc. (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Kirk Randal J, et al. – ‘SC 13D/A’ on 7/6/16 re: Ziopharm Oncology Inc

On: Wednesday, 7/6/16, at 4:25pm ET · Accession #: 1140361-16-71797 · File #: 5-79364

Previous ‘SC 13D’: ‘SC 13D/A’ on 7/5/16 · Next: ‘SC 13D/A’ on 9/9/16 · Latest: ‘SC 13D/A’ on 6/30/23

Amendment to General Statement of Beneficial Ownership — Sch. 13DFiling Table of Contents

To view the SGML, please refresh this page.

Amendment to General Statement of Beneficial Ownership — Sch. 13D
Filing Table of Contents

To view the SGML, please refresh
this page.